Compare Keel Infrastructure Corp. Common Stock (KEEL) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Keel Infrastructure Corp. Common Stock vs Relay Therapeutics Inc. Common Stock — how do they compare? Keel Infrastructure Corp. Common Stock trades at $3.08 (market cap $1.93B), while Relay Therapeutics Inc. Common Stock trades at $17.89 (market cap $3.82B). The key difference: Relay Therapeutics Inc. Common Stock is the larger of the two by market cap, and Relay Therapeutics Inc. Common Stock is trading nearer its 52-week high, Keel Infrastructure Corp. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Keel Infrastructure Corp. Common Stock for 1 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| KEEL | RLAY | |
|---|---|---|
Market Cap | $1.93B | $3.82B |
Volume | 30,868,523 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $6.66 | $20.75 |
52-Week Low | $1.71 | $6.03 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $2.25B | $2.93B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Keel Infrastructure Corp. Common Stock
Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.
Read more on KEEL →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
